Both in Pharmaceuticals
Bolt Biotherapeutics vs Pasithea Therapeutics
Over the past year BOLT returned +2.1% and KTTA returned −43.9%; their daily moves had a correlation of 0.05.
BOLT +2.1% KTTA −43.9%Growth of $1, one year, split-adjusted
| Metric | BOLT | KTTA |
|---|---|---|
| Price | $6.37 | $0.3973 |
| Market cap | $15.0M | $13.3M |
| Today | −3.34% | −0.65% |
| 1 month | +84.1% | −17.2% |
| 6 months | +31.6% | −41.1% |
| Year to date | +16.5% | −69.2% |
| 1 year | +6.2% | −44.7% |
| Revenue growth (YoY) | −99.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −154400.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.2× | — |
| Net cash | $17.6M | $45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 111.2% | 77.2% |
| Short % of float | 1.1% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).